Sign in

CIK 0001821586

  • Large accelerated filer

MoonLake Immunotherapeutics

Sign in to watch
Ticker
MLTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Cayman Islands
Entity type
Operating
Phone
+41 415108022
Business address
DORFSTRASSE 29, ZUG, Switzerland, 6300
Former names
Helix Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-07-27 Reich Kristian Chief Scientific Officer Sale 10b5-1 −1,100 $20.00 $22K 2,711,198
2026-07-22 Reich Kristian Chief Scientific Officer Sale 10b5-1 −2,448 $20.00 $49K 2,712,298
2026-07-21 Reich Kristian Chief Scientific Officer Sale 10b5-1 −50,000 $20.02 $1.0M 2,714,746
2026-07-20 Reich Kristian Chief Scientific Officer Sale 10b5-1 −43,700 $20.09 $878K 2,764,746
2026-07-15 Reich Kristian Chief Scientific Officer Sale 10b5-1 −16,105 $20.01 $322K 2,808,446
2026-06-17 Reich Kristian Chief Scientific Officer Sale 10b5-1 −50,000 $19.43 $972K 2,824,551
2026-06-16 Reich Kristian Chief Scientific Officer Sale 10b5-1 −50,000 $18.70 $935K 2,874,551
2026-06-15 Reich Kristian Chief Scientific Officer Sale 10b5-1 −50,000 $18.89 $945K 2,924,551
2026-01-07 Reich Kristian Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +520,342 520,342
2025-12-19 Reich Kristian Chief Scientific Officer Conversion +35,389 35,389
2025-12-19 Reich Kristian Chief Scientific Officer Returned to the company −35,389 0
2025-12-19 Reich Kristian Chief Scientific Officer Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG −1,052 0
2025-12-09 Reich Kristian Chief Scientific Officer Sale −72,908 $14.43 $1.1M 0
2025-12-08 Reich Kristian Chief Scientific Officer Sale −130,000 $15.08 $2.0M 72,908
2025-09-02 Reich Kristian Chief Scientific Officer Conversion +48,978 202,908
2025-09-02 Reich Kristian Chief Scientific Officer Returned to the company −48,978 35,389
2025-02-27 Reich Kristian Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +139,273 139,273
2025-01-20 Reich Kristian Chief Scientific Officer Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG −1,456 1,052
2025-01-20 Reich Kristian Chief Scientific Officer Conversion +111,949 153,930
2025-01-20 Reich Kristian Chief Scientific Officer Returned to the company −111,949 84,367

Page 1 of 3 · 47 trades